n-methylpyrrolidine has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, K; Naiki, H; Ono, K; Yamada, M | 1 |
| Friedland, RP; Marcinowski, KJ; Salomon, AR; Zagorski, MG | 1 |
2 other study(ies) available for n-methylpyrrolidine and Alzheimer Disease
| Article | Year |
|---|---|
Nicotine breaks down preformed Alzheimer's beta-amyloid fibrils in vitro.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Culture Techniques; Dose-Response Relationship, Drug; Humans; Microscopy, Polarization; Neurofibrillary Tangles; Neurons; Nicotine; Pyridines; Pyrrolidines; Spectrometry, Fluorescence | 2002 |
Nicotine inhibits amyloid formation by the beta-peptide.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Amyloidosis; Chemical Precipitation; Circular Dichroism; Cotinine; Humans; Magnetic Resonance Spectroscopy; Molecular Sequence Data; Molecular Structure; Nicotine; Peptide Fragments; Protein Binding; Protein Structure, Secondary; Pyridines; Pyrrolidines; Spectrophotometry, Ultraviolet | 1996 |